What is NeoGenomics's price / sales?

NeoGenomics (NEO) reported price / sales of 1.3× in Q1 2026.

How has NeoGenomics's price / sales changed year-over-year?

NeoGenomics's price / sales decreased by 28.8% year-over-year, from 1.8× to 1.3×.

What is the long-term trend for NeoGenomics's price / sales?

Over 5 years (2020 to 2025), NeoGenomics's price / sales has grown at a -31.7% compound annual growth rate (CAGR), from 14.1× to 2.1×.

What does price / sales mean?

Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.

NeoGenomics NEO Price / sales

Price / sales at other companies

Labcorp HoldingsLH

1.6×+0.1×

Quest DiagnosticsDGX

1.9×+0.1×

Personalis, Inc.PSNL

10.3×+6.7×

Guardant HealthGH

11.2×+4.4×

Natera, Inc.NTRA

11.3×+0.9×

Tempus AI, Inc.TEM

5.9×-4.4×

Other financials

Income statement

See full

Revenue$186.7M+11.1%

Gross profit$80.9M+10.4%

Operating income-$18.2M+34.4%

Net income-$17.1M+34.0%

EPS (diluted)-$0.13+35.0%

Balance sheet

See full

Cash & equivalents$146.1M-57.8%

Total debt$66.3M+5.3%

Total equity$828.8M-6.7%

Total assets$1.3B-15.9%

Cash flow

See full

Operating cash flow-$8.1M+67.9%

CapEx$5.0M+11.1%

Free cash flow-$13.1M+56.0%

Valuation

See full

Market cap$1.68B-21.0%

Enterprise value$1.6B-5.6%

Profitability

See full

Gross margin43.2%-1.1pp

Operating margin-14.2%+1.1pp

Net margin-13.3%+2.4pp

FCF margin-4.9%—

Returns & leverage

See full

Return on equity-11.6%+6.2pp

Debt / equity0.1×0.0×

Current ratio4.4×+2.4×

Where this comes from

Calculated from NeoGenomics’s reported figures.

market cap/total revenue=1.3×

Based on the most recent quarter.

The official record: NeoGenomics’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about NeoGenomics's price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is NeoGenomics's price / sales?: NeoGenomics (NEO) reported price / sales of 1.3× in Q1 2026.
How has NeoGenomics's price / sales changed year-over-year?: NeoGenomics's price / sales decreased by 28.8% year-over-year, from 1.8× to 1.3×.
What is the long-term trend for NeoGenomics's price / sales?: Over 5 years (2020 to 2025), NeoGenomics's price / sales has grown at a -31.7% compound annual growth rate (CAGR), from 14.1× to 2.1×.
What does price / sales mean?: Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.